Abilify MyCite and Meruvax II
Determining the interaction of Abilify MyCite and Meruvax II and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aripiprazole
Brand name: Abilify MyCite, Abilify, Abilify Discmelt, Abilify Maintena, Aristada, Aristada Initio
Synonyms: Abilify Mycite
Generic Name: rubella virus vaccine
Brand name:
Synonyms: Meruvax II (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abilify MyCite-Mesalamine
- Abilify MyCite-Mesalamine Controlled-Release Capsules
- Abilify MyCite-Mesalamine Delayed Release Tablets
- Abilify MyCite-Mesalamine Long-Acting Capsules (Apriso)
- Abilify MyCite-Mesalamine Long-Acting Capsules (Delzicol)
- Abilify MyCite-Mesalamine Long-Acting Capsules (Pentasa)
- Meruvax II-Abiraterone
- Meruvax II-Abiraterone acetate
- Meruvax II-Abiraterone Acetate (Yonsa)
- Meruvax II-Abiraterone Acetate (Zytiga)
- Meruvax II-Ablavar
- Meruvax II-Ablysinol